Clinical implication of persistent left superior vena cava isolation for atrial fibrillation
Pacing and Clinical Electrophysiology · 2024
DOI: 10.1111/pace.14911 ↗At a glance
Leserbrief in Pacing and Clinical Electrophysiology, 2024. Written by Naoya Kataoka and 1 co-authors. Institution: Second Department of Internal Medicine, University of Toyama, Toyama, Japan. Major MEDLINE topics: Atrial Fibrillation, Persistent Left Superior Vena Cava, Catheter Ablation. Cited 1 times so far (Crossref); 3 references.
Abstract (original language)
Chen et al. conducted a retrospective evaluation of patients presenting with persistent left superior vena cava (PLSVC) who underwent catheter ablation for atrial fibrillation (AF). 1 Within the cohort, a considerable number experienced AF recurrence after undergoing solely pulmonaryveinisolation(PVI).However, amongthose whounderwent secondary isolation targeting the PLSVC, successful clinical outcomes were achieved, halting the recurrence of AF. The authors inferred that empirical isolation of the PLSVC, beyond PVI, could serve as a viable and safe strategy in forestalling AF recurrence in individuals with concurrent PLSVC.
Subjects
MeSH terms (MEDLINE)
Authors and institutions
- Second Department of Internal Medicine, University of Toyama, Toyama, Japan.
ORCID profiles: Teruhiko Imamura
Cite
APA
Kataoka, N., & Imamura, T. (2024). Clinical implication of persistent left superior vena cava isolation for atrial fibrillation. Pacing and Clinical Electrophysiology. https://doi.org/10.1111/pace.14911
Vancouver
Kataoka N, Imamura T. Clinical implication of persistent left superior vena cava isolation for atrial fibrillation. Pacing and Clinical Electrophysiology. 2024. doi:10.1111/pace.14911
BibTeX
@article{Kataoka2024,
author = {Kataoka, Naoya and Imamura, Teruhiko},
title = {Clinical implication of persistent left superior vena cava isolation for atrial fibrillation},
journal = {Pacing and Clinical Electrophysiology},
year = {2024},
doi = {10.1111/pace.14911}
}
EUVIMED